StonvexLoading…
StonvexStonvexStonvexCore line items from QXO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $6.84B | $56.90M | $54.52M |
Operating Income | $-245.20M | $-71.00M | $-1.31M |
Net Income | $-279.40M | $28.00M | $-1.07M |
EPS (Diluted) | $-0.63 | $-0.11 | $-1.63 |
Total Assets | $15.89B | $5.10B | $20.50M |
Total Liabilities | $6.18B | $45.40M | $13.02M |
Cash & Equivalents | $2.36B | $5.07B | $6.14M |
Free Cash Flow OCF − CapEx | $183.20M | $84.70M | $463.00K |
Shares Outstanding | 674.50M | 409.40M | 664.45K |